Figaro Apothecary, Inc. – Trademark Portfolio
Entity Type: 03
Figaro Apothecary, Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include AGAVAPLEX. The owner is based in New York, NY.
15 Park Row Penthouse East
New York, NY 10038
Showing of trademarks Trademarks
Trademark Classifications
Figaro Apothecary, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Advertising; business management; business administration; office functions
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Figaro Apothecary, Inc. have?
Figaro Apothecary, Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending, 1 abandoned.
What trademark classes does Figaro Apothecary, Inc. file in?
Figaro Apothecary, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 35 (Advertising & Business), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are Figaro Apothecary, Inc.'s most well-known trademarks?
Figaro Apothecary, Inc.'s registered trademark portfolio includes well-known marks such as AGAVAPLEX. These are among 1 currently registered trademark in the portfolio.
What is Figaro Apothecary, Inc.'s trademark registration success rate?
Figaro Apothecary, Inc. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.